Search

You searched for "urine"

789 results found
European Urology journal front cover.

How to handle the opening market in robotic surgery

8 January 2025 | | URO - Urologic Oncology
In the latest edition of European Urology, Thillou et al. present a groundbreaking case series comprising 10 instances of robotassisted radical prostatectomy (RARP) procedures conducted using the innovative Dexter robotic system by Distalmotion SA, Épalinges, Switzerland. This marks the maiden...
Journal of Clinical Urology front cover image.

Preoperative risk stratification of high-risk prostate cancer patients

4 September 2025 | | URO - Urologic Oncology
High-risk prostate cancer (HRPCa) is associated with a significant risk of recurrence after radical treatment. While several classification systems exist, the D’Amico criteria – based on clinical T stage ≥T2c, prostate specific antigen (PSA) ≥20 ng/mL, or Gleason score (GS)...

An effective new solution for chronic pelvic pain patients

4 March 2022 | Research & Development
The Feel Free Programme is a safe, effective innovation which addresses the overwhelming caseload pressure on clinics because patients can start right now...

medac Pharma launch education platform, medac Academy

8 April 2022 | Research & Development, Company Profiles
medac Pharma have launched a new digital education platform for UK healthcare professionals, medac Academy.

New CPD Course Advances LATP Biopsy Skills for Clinicians

9 May 2025 | Company Profiles, Research & Development
Mermaid Medical, in collaboration with Fujifilm, recently delivered the first session of a new CPD-accredited training course focused on Local Anaesthetic Transperineal Prostate (LATP) biopsy procedures. Hosted at the advanced Fujifilm House in Bedford, the workshop welcomed healthcare professionals for...
European Urology journal front cover.

Prostate cancer detection in younger men

7 January 2026 | | URO - Urologic Oncology
Prostate cancer (PC) screening using prostate-specific antigen (PSA) testing with systematic biopsy (SBx) reduces mortality but risks overdiagnosis and unnecessary biopsies. Multiparametric MRI (mpMRI) enables MRI-targeted biopsy (TBx) of suspicious lesions and is now recommended before biopsy, although its role...

The role of specialist therapeutic radiographers in the treatment and care of men with prostate cancer

1 March 2016 | | URO - Urologic Oncology
The Statement of Intent: Cancer Strategy for England: 2015-2020 indicates that the number of people diagnosed with cancer each year will continue to grow rapidly due to the ageing population. There is also a requirement to diagnose and offer patients...

Priapism in sickle cell disease

2 March 2022 | | URO - Andrology
What is sickle cell disease? Sickle cell disease (SCD) is one of the most common single-gene disorders in the UK affecting approximately one in every 2000 live births. Approximately 20-25 million people worldwide have SCD. It predominately affects those of...

REPORT: Urology News Patient Engagement Evenings

6 November 2020 |
Towards the end of 2019 the team at Urology News began making plans for our first event. An educational study day focusing on how to improve patient engagement in urology was to be held in Edinburgh at the end of...

An amateur’s trek into the Urology Boot Camp

9 September 2025 | | URO - Core Urology
Driven by a strong desire to pursue a career in medicine, I was lucky to get an opportunity to attend the Urology Boot Camp at Leeds while still in sixth form. Although urology is a postgraduate specialty, I wanted to...

Feeling like a fraud — imposter syndrome: what it is and what to do about it

17 April 2024 | | URO - Core Urology
Have you ever been plagued by feelings of incompetence despite evidence to the contrary, then this article is for you. Dr Dunay Schmulian provides insight into imposter syndrome and what to do about it. Excerpt 1 Consultant:That was excellent, and...

Testing radical prostatectomy in men with prostate cancer and oligometastases to the bone: a randomised controlled feasibility study

1 May 2017 | | URO - Urologic Oncology
Prostate cancer is the commonest cancer and the second most frequent cause of cancer death in Western men [1]. The recent STAMPEDE data suggests a median survival of just 42.1 months in the control arm of metastatic men [2]. Current...